Internal Medicine, Rheumatology · San Juan, PR
NPI
1669457875
Since 2005
Specialty
Internal Medicine, Rheumatology
Code 207RR0500X
Group practices
0
Medicare group memberships
Hospitals
0
Hospital affiliations
400 F.D. Roosevelt Ave., Clinica Las Americas, Suite 404
San Juan, PR, 00918
Phone (787) 765-3245
Medicare paid, 2024
$43K
1,081 services
Medicare patients, 2024
195
Average age 76
Drug cost, 2024
$8.6M
5,693 prescriptions
Company payments, 2025
$41K
From 16 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Radames Sierra-Zorita was code 99213 (office e&m - established), 449 times for 172 patients. In total Radames Sierra-Zorita billed 1,081 services in 10 codes, and Medicare paid $43K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2010-02-05.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99213 Office E&M - Established | Office | 449 | 172 | $66.14 | $30K |
| J3301 Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 351 | 71 | $0.73 | $257 |
| 20610 Joint Injection | Office | 132 | 66 | $46.73 | $6,168 |
| 99212 Office E&M - Established | Office | 76 | 48 | $43.89 | $3,335 |
| 20605 Joint Injection | Office | 25 | 19 | $39.88 | $997 |
| 20600 Joint Injection | Office | 23 | 18 | $36.80 | $846 |
| 99203 Office E&M - New | Office | 15 | 15 | $87.54 | $1,313 |
By year: 2022 $48K for 1,455 services; 2023 $49K for 1,388 services; 2024 $43K for 1,081 services.
Medicare prescription drug claims, 2024
In 2024, the drug Radames Sierra-Zorita prescribed most often to Medicare patients was Methotrexate (Methotrexate Sodium), with 1,365 prescriptions and refills. In total Radames Sierra-Zorita wrote 5,693 Medicare prescriptions that cost $8.6M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Methotrexate Methotrexate Sodium | 1,365 | 1,406 | 234 | $27K |
| Leucovorin Calcium Generic | 363 | 395 | 68 | $9,843 |
| Humira(Cf) Pen Adalimumab | 275 | 275 | 30 | $1.9M |
| Sulfasalazine Generic | 260 | 310 | 57 | $7,235 |
| Duloxetine Hcl Generic | 223 | 253 | 65 | $4,141 |
| Prednisone Generic | 219 | 239 | 77 | $1,804 |
| Hydroxychloroquine Sulfate Generic | 206 | 265 | 44 | $9,764 |
| Rinvoq Upadacitinib | 198 | 198 | 20 | $1.3M |
| Folic Acid Generic | 172 | 198 | 39 | $738 |
| Leflunomide Generic | 161 | 191 | 26 | $12K |
| Enbrel Sureclick Etanercept | 150 | 150 | 18 | $1.1M |
| Gabapentin Generic | 130 | 148 | 42 | $1,415 |
| Prolia Denosumab | 128 | 768 | 78 | $224K |
| Diclofenac Potassium Generic | 118 | 118 | 37 | $6,264 |
| Kevzara Sarilumab | 111 | 111 | 11 | $482K |
Brand drugs: - claims; generic drugs: 3,704 claims; opioid claims: 17.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Radames Sierra-Zorita $41K ($41K in general payments such as food, travel and fees) from 16 companies. The largest payer was Abbvie Inc. with $15K.
| Company | Payments | Amount |
|---|---|---|
| Abbvie Inc. ABBV | 37 | $15K |
| Amgen Inc. AMGN | 29 | $13K |
| Radius Health, Inc. | 14 | $11K |
| Novartis Pharmaceuticals Corporation NVS | 22 | $516 |
| UCB, Inc. UCB.BR | 8 | $419 |
| AstraZeneca Pharmaceuticals LP AZN | 3 | $266 |
| Pbg Puerto Rico LLC | 4 | $232 |
| Mallinckrodt Hospital Products Inc. | 4 | $212 |
| Janssen Pharmaceuticals, Inc JNJ | 6 | $174 |
| Genzyme Corporation SNY | 1 | $141 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.